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Abstract We report the methodol-
ogy of an epidemiological survey
of the prevalences of migraine,
tension-type headache and chronic
daily headache in Georgia.
Medical residents visited adjacent
households in Tbilisi to interview
a pre-defined target of 100 biologi-
cally unrelated subjects. All
respondents reporting headache in
the previous year, as well as ran-
dom 20 non-headache controls,
were examined by a neurologist.
The response rate was 70%. Of
156 respondents, 93 were biologi-
cally unrelated and 45 (48%)
reported headache in the previous
year. Eight subjects fulfilled all
IHS criteria for migraine (1-year
prevalence 8.6% [95% CI:
2.9–14.3%]), and 13 had probable
migraine, meeting all but the crite-
rion for duration. Nineteen had
tension-type headache (20.4%
[95% CI: 12.2–28.6%]) and five
had chronic daily headache (5.4%
[95% CI: 1–10.0%]). In compar-
isons of diagnoses by question-
naire and neurologist (considered
the gold standard), sensitivities for
the questionnaire of 89% for
migraine and 67% for tension-type
headache were calculated (overall
kappa=0.74).
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Primary headache disorders, principally migraine and ten-
sion-type headache, affect up to 80% of the general popu-
lation and are among the most important public health
problems throughout the world. Whilst the prevalence and
socioeconomic impact of migraine, and to a lesser extent
of tension-type headache, have been studied many times
in the last 20 years, the majority of surveys have been per-
formed in the developed countries of Western Europe and
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North America [1]. Only a few have been carried out in
Eastern Europe, and no data are available from the coun-
tries of the former Soviet Union.
In recognition of the scale of the global problem, three
major international headache non-governmental organisa-
tions, in collaboration with the World Health Organization
(WHO), have committed to the initiative “Lifting The
Burden: The Global Campaign to Reduce the Burden of
Headache Worldwide” [2]. The Global Campaign aims, in
its first stage, to fill the gaps in the knowledge of
headache-related burden worldwide.
The International Headache Society (IHS) has estab-
lished its Russian Linguistic Subcommittee, to promote
knowledge of headache and encourage the interest of
physicians in countries of the former Soviet Union. In a
collaborative enterprise between these two, a working
group has been formed of representatives from Armenia,
Azerbaijan, Byelorussia, Georgia, Moldova and Russia
which, as a primary goal, seeks to perform a burden-of-ill-
ness study of headache in these countries. A successful
epidemiological study will provide data on prevalence and
socioeconomic impact of the important headache disor-
ders in the general populations of these countries as a pre-
lude to planning and implementing, with local health pol-
icy makers and the Global Campaign, health-care pro-
grammes for headache where none currently exist.
The infrastructure of Georgia is such that neither tele-
phone nor postal surveys are likely to be effective, and it
is necessary to carry out such a study by interviews con-
ducted through door-to-door visits. The method requires
testing in a pilot study before use in a full survey, and this
is reported here. The aim was to validate methodology
that could be used for epidemiological studies of headache
in all countries of the former Soviet Union and possibly
other developing countries worldwide.
Patients and methods
The study protocol was approved by the Georgian National
Council on Bioethics.
Questionnaire
We adapted a questionnaire that had been used and validated for
epidemiological headache research in Germany [3]. It was trans-
lated from German into the Georgian language by ZK. It had four
parts: (a) personal data; (b) a medical enquiry, including questions
related to migraine, tension-type headache, trigeminal autonomic
cephalalgias and the use of acute and preventative headache med-
ication as well as any other medications; (c) sociodemographic
status evaluation; and (d) enquiry into willingness to pay (WTP)
for acute and preventative headache medication. The medical
enquiry began with a screening question: “Have you had headache
last year not related to flu, hangover, cold or head injury?”, as rec-
ommended by earlier studies [4, 5]. Subjects who responded “yes”
to this question were asked to complete the questionnaire.
Subjects who responded “no” were asked to respond to the demo-
graphic and general medical questions only. Questions relating to
migraine, tension-type headache and trigeminal autonomic cepha-
lalgias were based on IHS diagnostic criteria [6]. From the
German experience we expected to achieve high sensitivity and
specificity for migraine and tension-type headache but be able
only to screen for possible cluster headache [7]. The questions on
WTP were asked according to the bidding game method [8].
Briefly, they asked subjects with headache how much money they
would spend per month for an effective medication package
defined as medication achieving “very good” pain relief for acute
headache coupled with preventative medication reducing
headache frequency by more than one half. The bidding began by
first asking whether the individual would pay 15 Georgian Lari
(GEL, approximately USD 7.5) for the package. If the answer was
“yes”, the interviewer incremented the bid in steps of GEL 5 until
the answer was “no”. The last sum of money receiving a “yes”
response was then the WTP result from this bidding game
approach. If the initial answer was “no”, the interviewer reduced
the bid by GEL 5 and continued this process until the respondent
said “yes”. The first sum of money receiving a “yes” response was
the WTP result in these cases.
As a first step, the questionnaire was presented to a few
available patients with migraine and tension-type headache seen
in the Department of Neurology of the Tbilisi Medical Academy.
As no headache outpatient clinic existed in Georgia, we had no
possibility of testing the questionnaire more thoroughly in an
outpatient setting. We therefore decided to perform the valida-
tion during the pilot epidemiological study.
Pilot epidemiological study
The total population of the Republic of Georgia in 2000 was
4,435,200 inhabitants, 53% urban and 47% rural, with 1 080 000
inhabitants in the capital city, Tbilisi. The study was conducted
in two districts of Tbilisi that were representative for demo-
graphic structure of the entire population of the city and occu-
pied by multi-storey apartment buildings with 40–100 house-
holds per building.
We used the “cold-calling” method of door-to-door survey
(calling unannounced), visiting adjacent front doors of residen-
tial buildings. This decision was based on the following consid-
erations: (a) a door-to-door survey performed by medical resi-
dents would ensure a high quality of collected information; (b)
the low income levels in Georgia made it feasible to provide
salaries for medical residents engaged for the task; (c) participa-
tion in a study organised by IHS would be encouraging for
young physicians and ensure high levels of enthusiasm and
therefore high methodological quality; (d) lack of infrastructure
(e.g., functioning postal service, telephone lists, etc.) made other
methods impossible.
Three medical residents performed the door-to-door survey.
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Consecutive adjacent households were contacted until a pre-
defined target number of 100 biologically non-related subjects
was achieved. In cases of refusal, subjects were considered as
non-responders. If nobody opened the door, surveyors returned
once. If nobody responded for the second time, the adjacent
household was contacted in its place.
We differentiated between the main and secondary members
of the household: husband and wife, together with any other bio-
logically unrelated adults, were considered as the main study
population, while children, grandmothers, grandfathers, aunts,
uncles and other relatives were secondary household members.
All main and secondary adult family members were interviewed
by surveyors using the standard headache questionnaire. Data
from the main study population were included in the primary
analysis to calculate the prevalence and burden of headache in
the general population. Data from both main and secondary adult
study populations were used for validation of the questionnaire.
Each subject who reported headache not related to flu, hang-
over, cold or head injury in the previous year was invited for
neurological interview and examination which were performed
by one of two neurologists who had trained in the field of
headache for two years at the Department for Neurology,
University of Essen. At this interview, primary headache disor-
ders were diagnosed according to IHS criteria and, when neces-
sary, symptomatic headaches were excluded by neurological
examination and cranial CT/MRI. Of respondents not reporting
headache, 20 were randomly selected and also invited for neuro-
logical examination. The neurologists were not aware of any
responses to the questionnaire.
Analysis
Data analysis was performed by SPSS 13.0 and BiAS 8.0.
Comparisons of interval-scaled variables were made using
Student’s t-test and of ordinal-scaled variables using the chi-
squared test. The level of significance was set at p<0.05.
Sensitivity and specificity of the questionnaires for migraine
and tension-type and for the combination of migraine and ten-
sion-type headache were calculated by comparing questionnaire-
based diagnoses with the diagnoses made at neurological inter-
view (physician diagnoses), the latter being considered the gold
standard. Cohen’s kappa was calculated for the overall agree-
ment of questionnaire- and physician-diagnoses.
Crude prevalences of migraine, tension-type headache and
chronic daily headache, with 95% confidence intervals (CI),
were calculated as recommended by Bortz [9].
Results
Seventy adjacent households were contacted. Of these, 49
households (70%) were interviewed whilst 21 refused.
Individuals who refused the interview tended to be
younger (42.1±10.0 vs. 49.2±12.2 years [not significant])
and male (M:F ratio 40:60 among non-responders and
35:65 among responders [not significant]).
We faced a serious problem of suspicion and mistrust
amongst householders, which had two main origins: (a)
general mistrust of unknown persons asking to open
doors, which derived from the relatively high level of
crime; and (b) specific mistrust towards an offer of inter-
est in headache, which was not considered a “serious”
medical problem. In order to obtain the confidence of peo-
ple who were doubtful, surveyors asked for help from
neighbours who had been spontaneously willing to partic-
ipate. This strategy helped significantly to increase the
response rate.
The overall number of interviewed subjects was 156,
with the following family structure: 34 (22%) husbands,
45 (29%) wives, 52 (33%) children, 14 (9%) non-related
family members (e.g., daughter- or son-in-law) and 11
(7%) other relatives.
Of the 104 adults, 47 (45%) reported headache not
related to flu, hangover, cold or head injury in the previ-
ous year. Forty-four of these were seen by one of the neu-
rologists, together with 17 of 20 randomly selected sub-
jects who reported no headache (three subjects in each
group refused the invitation). Hence the validation of the
questionnaire was based on 61 respondents with headache
(43 [70%] females; mean age 42.6±13.9 years). According
to the physician diagnoses, 18 subjects (30%) had
migraine or probable migraine (in the latter case disre-
garding only the criterion of duration), 23 (38%) had ten-
sion-type headache, 5 (8%) had a combination of migraine
and tension-type headache and 15 (24%) were headache-
free. The sensitivity and specificity of the questionnaire
for migraine were 0.89 and 0.88 respectively, and for ten-
sion-type headache 0.67 and 0.78. The overall kappa was
0.74. As none of the subjects had any of the trigeminal
autonomic cephalalgias, we could not judge the validity of
the questionnaire for this diagnostic group.
The analysis of prevalences was based on 93 biologi-
cally unrelated subjects (60 [65%] females, mean age
49.6±11.5 years), of whom 45 (48%) had had headache in
the previous year (i.e., a current headache disorder). Of
this sample, 21 met IHS criteria for migraine or probable
migraine (disregarding duration), eight of whom fulfilled
all criteria (1-year prevalence: 8.6% [95% CI:
2.9–14.3%]); 19 had tension-type headache (1-year preva-
lence: 20.4% [95% CI: 12.2–28.6%]); and five had a
chronic daily headache syndrome (1-year prevalence:
5.4% [95% CI: 1–10.0%]), two of whom were overusing
acute headache medication. Table 1 shows the demo-
graphic and clinical characteristics of patients with
migraine, tension-type headache and chronic daily
headache. The vast majority of those with headache used
simple or combination analgesics for acute treatment of
headache. Some used ergots, but none used triptans. None
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had preventative medication.
The mean value for WTP was GEL 30.1±18.6 per
month (approximately USD 15).
Discussion
We were able to achieve three main goals of the study:
first, to construct a screening questionnaire for migraine
and tension-type headache in the Georgian language; sec-
ond, to use it to perform a pilot study, with plausible
results; and third, to learn how to undertake a full epi-
demiological study in Georgia.
The methodology of the door-to-door interviews
worked well. We achieved a response rate of 70%, which
can be considered quite high. We faced three main prob-
lems. First, we had to earn people’s confidence in a situa-
tion of general mistrust because of the high level of crime.
We therefore performed the study during the warm months
of spring, summer and early autumn. We asked people of
the neighbourhood who were more enthusiastic for help to
gain the confidence of others, and were finally able to
achieve a good response rate. The second challenge was the
fact that the general population, and even physicians, did
not consider headache to be a medical problem. Hence a
huge amount of educational work had to be done. The third
problem was related to data collection on expenditure.
Respondents either did not remember their spending well or
were reluctant to disclose this information. It should be said
that this a common problem, observed in many other popu-
lations and countries. People are mostly not keen to talk
about their finances. Our decision to use expenditure data
for classifying household socioeconomic status was based
on the understanding that they would speak more easily
about their expenditure than their income, but this may not
have been the case. This issue needs a more careful
approach and future exploration before a large epidemio-
logical study is conducted in the region.
The diagnostic questionnaire also worked fairly well:
the overall agreement between questionnaire and physi-
cian diagnoses was 0.74, which should be considered as a
strong agreement level [10]. The questionnaire showed
good sensitivities and specificities for migraine, but less
so for tension-type headache, which has fewer positive
features. Validity for trigeminal autonomic cephalalgias
could not be assessed, but, considering the experience
with the German version, we expect that it could be used
for screening only and all suspected cases would require
formal confirmation. We examined 17 subjects who were
headache-negative according to the questionnaire and
found two had episodic tension-type headache. This sug-
gests that we missed approximately 10% of people with a
headache disorder, which may not be surprising consider-
ing the neglect of headache as a medical problem.
The validation of the questionnaire is not finished. We
understand that the numbers of patients and controls so far
studied are not sufficient. Hence the validation will be con-
Table 1 Demographic and clinical characteristics of patients according to diagnosis
Headache N Females Age  Time since Headache Acute Overuse of Preventative Willingness
diagnosis (years) onset frequency headache acute medication to pay
(years) (d/mo) medication headache
medication
Probable or 21 19 (91%) 46.4±13.4 13.2±6.8 5.0±4.5 SA: 7 (33%) 3 (14%) None 33 GEL
definite CA: 11 (52%)
migraine E: 1 (5%)
None:2 (10%)
Definite 8 8 (100%) 47.6±9.3 17.4±6.3 3.5±2.2 SA: 3 (38%) 1 (12%) None 
migraine CA: 4 (50%)
E: 1 (12%)
Tension-type 19 13 (68%) 49.2±10.8 8.7±5.7 6.8±7.0 SA: 5 (26%) 1 (45) None 10 GEL
headache CA: 9 (47%)
None:5 (26%)
Chronic daily 5 4 (80%) 52.2±15.6 7.6±3.9 21.1±5.5 SA: 1 (20%) 2 (40%) None 43 GEL
headache CA: 4 (80%) 
SA, simple analgesics; CA, combination analgesics; E, ergot
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tinued during the main study. The preliminary data sug-
gest, however, that our questionnaire is comparable in
quality with others reported in the international literature.
The sensitivity and specificity values are quite similar to
those of the German version [3]. Several other validated
headache questionnaires exist, most of them constructed as
screening instruments for migraine and consisting of 3–8
items based on the IHS criteria [11–18]. Lipton et al. pre-
sented a very short screening questionnaire for migraine
with only three items and were able to achieve a sensitivi-
ty of 0.81 and specificity of 0.75, with a kappa of 0.68
[14]. More detailed migraine questionnaires have been pre-
sented by Kallela et al. [19] and Hagen et al. [20]. The for-
mer, for migraine only, obtained a sensitivity of 0.99 and a
specificity of 0.96, whilst the kappa value for the compar-
ison between telephone interview and clinical examination
was 0.85. Questionnaires seeking more than one diagnosis
result in considerably lower agreement levels. The ques-
tionnaire of Hagen et al. differentiated between migraine,
non-migraine headache and chronic daily headache with
kappa values of 0.59, 0.43 and 0.44 respectively [20]. The
questionnaire suggested by Rasmussen et al. for migraine,
episodic tension-type headache and chronic tension-type
headache achieved relatively low kappa values of 0.43,
0.30 and 0.24 respectively [10].
We found the 1-year prevalence of migraine or proba-
ble migraine (disregarding duration) to be 21.5%, of defi-
nite migraine 8.6%, of tension-type headache 20.4% and
of chronic daily headache 5.4%. We accept that the small
sample, from Tbilisi only, does not allow these findings to
be considered representative for the whole general popu-
lation of Georgia, but it is important that the observed
prevalences are comparable to those in the international
literature [1]. The methodology therefore provided plausi-
ble results, and can be used (with some improvements) for
a full country-wide epidemiological study.
An interesting finding was that, on average, people
within the sample were willing to pay GEL 30 (USD 15)
per month for the effective treatment of their headache.
This information is very important in the context of pub-
lic-health interventions. Considering the local prices for
over-the-counter analgesics and for generic beta-blockers
and valproic acid, and even the cost of some triptans, it is
evident that GEL 30 is enough to deliver acute and pre-
ventative medication to international standards. The phar-
maceutical industry has ignored the potential for drug
marketing in this and nearby countries. Not only has this
been to the likely disadvantage of people who might have
benefited from newer drugs: it may also have been com-
mercially misguided.
The likely impact of the full study from the public-
health perspective should not be underestimated. First, it
will provide evidence of the currently unquantified burden
of headache in Georgia. Second, it will serve as an exam-
ple for other countries of the Caucasus, a region with
approximately 15 million inhabitants for whom this
knowledge is also lacking. Third, it will draw the attention
of the medical community, as well as of the general popu-
lation, to the issue of headache as a common, important
but treatable medical problem. Fourth, it will stimulate the
teaching of doctors in the region, for whom headache dis-
orders have very low priority. Fifth, it may awaken the
pharmaceutical industry to possibilities that can be devel-
oped in their and in patients’ interests.
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